Get started
111

YICHANG HEC CHANGJIANG PHARMACTL CO

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

1558 chart


Full chart

1558 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.49 B‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
4.76
Basic EPS (TTM)
2.03 HKD
Net income (FY)
‪2.20 B‬ HKD
Revenue (FY)
‪6.96 B‬ HKD
Shares float
‪405.25 M‬
Beta (1Y)
0.32

Employees


Employees (FY)
‪4.62 K‬
Change (1Y)
+451 +10.82%
Revenue / Employee (1Y)
‪192.84 K‬ HKD
Net income / Employee (1Y)
‪61.04 K‬ HKD

About YICHANG HEC CHANGJIANG PHARMACTL CO


Sector
Health Technology
CEO
Jun Cai Jiang
Headquarters
Yichang
Website
cj.hec.cn
Founded
2001
ISIN
CNE1000023R6
FIGI
BBG00BNKGQL7
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases, and others. Its products include Benzbromarone, Telmisartan, Amlodipine Besylate, and Cetirizine Hydrochloride. The company was founded on August 8, 2001 and is headquartered in Yichang, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

1558 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 1558 is 9.54 HKD — it has decreased by −1.14% in the past 24 hours. Watch YICHANG HEC CHANGJIANG PHARMACTL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange YICHANG HEC CHANGJIANG PHARMACTL CO stocks are traded under the ticker 1558.
1558 stock has risen by 1.81% compared to the previous week, the month change is a 6.35% rise, over the last year YICHANG HEC CHANGJIANG PHARMACTL CO has showed a 13.17% increase.
We've gathered analysts' opinions on YICHANG HEC CHANGJIANG PHARMACTL CO future price: according to them, 1558 price has a max estimate of 13.80 HKD and a min estimate of 13.80 HKD. Watch 1558 chart and read a more detailed YICHANG HEC CHANGJIANG PHARMACTL CO stock forecast: see what analysts think of YICHANG HEC CHANGJIANG PHARMACTL CO and suggest that you do with its stocks.
1558 reached its all-time high on Jan 21, 2020 with the price of 27.23 HKD, and its all-time low was 3.35 HKD and was reached on Nov 2, 2021. View more price dynamics on 1558 chart.
See other stocks reaching their highest and lowest prices.
1558 stock is 3.21% volatile and has beta coefficient of 0.32. Track YICHANG HEC CHANGJIANG PHARMACTL CO stock price on the chart and check out the list of the most volatile stocks — is YICHANG HEC CHANGJIANG PHARMACTL CO there?
Today YICHANG HEC CHANGJIANG PHARMACTL CO has the market capitalization of ‪8.49 B‬, it has increased by 2.77% over the last week.
Yes, you can track YICHANG HEC CHANGJIANG PHARMACTL CO financials in yearly and quarterly reports right on TradingView.
YICHANG HEC CHANGJIANG PHARMACTL CO is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
1558 net income for the last half-year is ‪741.99 M‬ HKD, while the previous report showed ‪1.04 B‬ HKD of net income which accounts for −28.69% change. Track more YICHANG HEC CHANGJIANG PHARMACTL CO financial stats to get the full picture.
YICHANG HEC CHANGJIANG PHARMACTL CO dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪4.62 K‬ employees. See our rating of the largest employees — is YICHANG HEC CHANGJIANG PHARMACTL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. YICHANG HEC CHANGJIANG PHARMACTL CO EBITDA is ‪2.72 B‬ HKD, and current EBITDA margin is 51.56%. See more stats in YICHANG HEC CHANGJIANG PHARMACTL CO financial statements.
Like other stocks, 1558 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YICHANG HEC CHANGJIANG PHARMACTL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So YICHANG HEC CHANGJIANG PHARMACTL CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating YICHANG HEC CHANGJIANG PHARMACTL CO stock shows the buy signal. See more of YICHANG HEC CHANGJIANG PHARMACTL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.